Varadha Balaji Venkadakrishnan

17PUBLICATIONS
110CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer cell biologyMedical physics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 31, 2026
Vitronectin Enrichment in Prostate Cancer Liver Metastases Promotes Adhesion and Survival.

|Feb 20, 2026
Crosstalk between EZH2 and DNA methylation mediates neuroendocrine prostate cancer lineage plasticity.

Richa Singh, Varadha Balaji Venkadakrishnan, Eddie Imada

|Aug 21, 2025
Epigenetic Derepression of PROX1 Promotes Neuroendocrine Prostate Cancer Progression.

Varadha Balaji Venkadakrishnan, Adam Presser, Nathaniel C E Voss

|Jul 02, 2025
Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer.

Kei Mizuno, Sheng-Yu Ku, Varadha Balaji Venkadakrishnan

|Apr 01, 2025
Targeting the tumour cell surface in advanced prostate cancer.

Cristina Boixareu, Tarek Taha, Varadha Balaji Venkadakrishnan

|Nov 20, 2024
Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer.

Shankha S Chatterjee, Juan F Linares, Tania Cid-Diaz

Pageof 3

Frequent Collaborators

12 joint publications

Himisha Beltran

9 joint publications

Martin K Bakht

5 joint publications

Sheng-Yu Ku

4 joint publications

David S Rickman